BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 23841899)

  • 1. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
    Parikh SA; Rabe KG; Call TG; Zent CS; Habermann TM; Ding W; Leis JF; Schwager SM; Hanson CA; Macon WR; Kay NE; Slager SL; Shanafelt TD
    Br J Haematol; 2013 Sep; 162(6):774-82. PubMed ID: 23841899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.
    Rossi D; Cerri M; Capello D; Deambrogi C; Rossi FM; Zucchetto A; De Paoli L; Cresta S; Rasi S; Spina V; Franceschetti S; Lunghi M; Vendramin C; Bomben R; Ramponi A; Monga G; Conconi A; Magnani C; Gattei V; Gaidano G
    Br J Haematol; 2008 Jun; 142(2):202-15. PubMed ID: 18492108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
    Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
    Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How we treat Richter syndrome.
    Parikh SA; Kay NE; Shanafelt TD
    Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
    Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
    Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
    Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
    Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
    Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
    Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive markers and driving factors behind Richter syndrome development.
    Fangazio M; De Paoli L; Rossi D; Gaidano G
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):433-42. PubMed ID: 21417856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
    Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
    Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia.
    Fan L; Wang L; Zhang R; Fang C; Zhu DX; Wang YH; Zou ZJ; Li JY; Xu W
    Leuk Lymphoma; 2012 Sep; 53(9):1749-56. PubMed ID: 22329349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
    Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
    Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
    Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
    Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
    Bouclet F; Calleja A; Dilhuydy MS; Véronèse L; Pereira B; Amorim S; Cymbalista F; Herbaux C; de Guibert S; Roos-Weil D; Hivert B; Aurran T; Dupuis J; Blouet A; Tchernonog E; Laribi K; Dmytruck N; Morel P; Michallet AS; Dartigeas C; Tournilhac O; Nguyen-Khac F; Delmer A; Feugier P; Ysebaert L; Guièze R
    Ann Hematol; 2021 Apr; 100(4):987-993. PubMed ID: 33495922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.